Phenobarbital-mediated increase in ring- and N-hydroxylation of the carcinogen N-2-fluorenylacetamide, and decrease in amounts bound to liver deoxyribonucleic acid

The effect of phenobarbital (PB) pretreatment of young male rats on the metabolism in vivo and in vitro of the carcinogen N -2-fluorenylacetamide (FAA) was studied. PB increased the urinary excretion of 14 C from labeled FAA, mainly as met-abolites conjugated with glucuronic acid. There was a small drop in excretion of sulfuric acid conjugates. In the glucosiduronic acid fraction, there were increases in the N - and 7-hydroxy derivatives of FAA and a decrease in the 5-hydroxy compound, while the 3-hydroxy metabolite was virtually unchanged. The concentration of metabolites of FAA in the liver was considerably lower, as was the amount of isotope bound to DNA. This important finding, correlated with a reduced carcinogenicity of FAA in rats given PB, is ascribed to increased conjugation with glucuronic acid and lesser formation of sulfate esters. The microsomal fraction in vitro from the livers of young rats yielded metabolites of FAA, in decreasing order, hydroxylated at 7-, 5-, N - and 3-. Carbon monoxide significantly inhibited formation of the 7-hydroxy metabolite but elevated somewhat that of the N -hydroxy compound. Pretreatment with PB increased cytochrome P-450 and hydroxylation at all positions 2- to 4-fold, the greatest effect being with N -hydroxy-FAA. With microsomes from PB-treated rat livers, carbon monoxide depressed hydroxylation at the 3-position, while N -hydroxylation was least affected. Because hydroxylation of FAA occurs at several well-defined ring positions and on the amido nitrogen, FAA is a good substrate to explore the mechanisms of hydroxylation reactions. The data obtained suggest that these metabolic reactions are performed by a family of related enzyme systems.